Comment: PD-1 targeting MK-3475 gives long-term responses in melanoma

Comment: Immunotherapy combo increases median survival in advanced melanoma

Success for ipilimumab and nivolumab combo in advanced melanoma

Comment: CALGB/SWOG 80405 study on chemo combos in colorectal

Discontinuing statins near the end of life is safe, improves patient quality of life

First-line bevacizumab plus chemo and cetuximab plus chemo provide similar survival benefits in metastatic colorectal cancer

Impact of cytotoxics on pregnancy needs to be better understood

T-VEC injections into melanoma lesions show significant response rate

Addition of docetaxel to initial hormone therapy substantially improves survival in metastatic, hormone-sensitive prostate cancer

Lapatinib not found to be beneficial in head and neck cancer with high risk of recurrence

ASCO 2014 roundup

Lower-dose radiation safe for certain lower-risk, HPV-positive head and neck cancers